
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC

Recordati Industria Chimica e Farmaceutica SpA?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
47.42
60.95
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Recordati Industria Chimica e Farmaceutica SpA hold over its rivals?
What risks and challenges
does Recordati Industria Chimica e Farmaceutica SpA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Recordati Industria Chimica e Farmaceutica SpA.
Provide an overview of the primary business activities
of Recordati Industria Chimica e Farmaceutica SpA.
What unique competitive advantages
does Recordati Industria Chimica e Farmaceutica SpA hold over its rivals?
What risks and challenges
does Recordati Industria Chimica e Farmaceutica SpA face in the near future?
Summarize the latest earnings call
of Recordati Industria Chimica e Farmaceutica SpA.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Recordati Industria Chimica e Farmaceutica SpA.
Provide P/S
for Recordati Industria Chimica e Farmaceutica SpA.
Provide P/E
for Recordati Industria Chimica e Farmaceutica SpA.
Provide P/OCF
for Recordati Industria Chimica e Farmaceutica SpA.
Provide P/FCFE
for Recordati Industria Chimica e Farmaceutica SpA.
Provide P/B
for Recordati Industria Chimica e Farmaceutica SpA.
Provide EV/S
for Recordati Industria Chimica e Farmaceutica SpA.
Provide EV/GP
for Recordati Industria Chimica e Farmaceutica SpA.
Provide EV/EBITDA
for Recordati Industria Chimica e Farmaceutica SpA.
Provide EV/EBIT
for Recordati Industria Chimica e Farmaceutica SpA.
Provide EV/OCF
for Recordati Industria Chimica e Farmaceutica SpA.
Provide EV/FCFF
for Recordati Industria Chimica e Farmaceutica SpA.
Provide EV/IC
for Recordati Industria Chimica e Farmaceutica SpA.
Show me price targets
for Recordati Industria Chimica e Farmaceutica SpA made by professional analysts.
What are the Revenue projections
for Recordati Industria Chimica e Farmaceutica SpA?
How accurate were the past Revenue estimates
for Recordati Industria Chimica e Farmaceutica SpA?
What are the Net Income projections
for Recordati Industria Chimica e Farmaceutica SpA?
How accurate were the past Net Income estimates
for Recordati Industria Chimica e Farmaceutica SpA?
What are the EPS projections
for Recordati Industria Chimica e Farmaceutica SpA?
How accurate were the past EPS estimates
for Recordati Industria Chimica e Farmaceutica SpA?
What are the EBIT projections
for Recordati Industria Chimica e Farmaceutica SpA?
How accurate were the past EBIT estimates
for Recordati Industria Chimica e Farmaceutica SpA?
Compare the revenue forecasts
for Recordati Industria Chimica e Farmaceutica SpA with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Recordati Industria Chimica e Farmaceutica SpA and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Recordati Industria Chimica e Farmaceutica SpA against its competitors.
Analyze the profit margins
(gross, operating, and net) of Recordati Industria Chimica e Farmaceutica SpA compared to its peers.
Compare the P/E ratios
of Recordati Industria Chimica e Farmaceutica SpA against its peers.
Discuss the investment returns and shareholder value creation
comparing Recordati Industria Chimica e Farmaceutica SpA with its peers.
Analyze the financial leverage
of Recordati Industria Chimica e Farmaceutica SpA compared to its main competitors.
Show all profitability ratios
for Recordati Industria Chimica e Farmaceutica SpA.
Provide ROE
for Recordati Industria Chimica e Farmaceutica SpA.
Provide ROA
for Recordati Industria Chimica e Farmaceutica SpA.
Provide ROIC
for Recordati Industria Chimica e Farmaceutica SpA.
Provide ROCE
for Recordati Industria Chimica e Farmaceutica SpA.
Provide Gross Margin
for Recordati Industria Chimica e Farmaceutica SpA.
Provide Operating Margin
for Recordati Industria Chimica e Farmaceutica SpA.
Provide Net Margin
for Recordati Industria Chimica e Farmaceutica SpA.
Provide FCF Margin
for Recordati Industria Chimica e Farmaceutica SpA.
Show all solvency ratios
for Recordati Industria Chimica e Farmaceutica SpA.
Provide D/E Ratio
for Recordati Industria Chimica e Farmaceutica SpA.
Provide D/A Ratio
for Recordati Industria Chimica e Farmaceutica SpA.
Provide Interest Coverage Ratio
for Recordati Industria Chimica e Farmaceutica SpA.
Provide Altman Z-Score Ratio
for Recordati Industria Chimica e Farmaceutica SpA.
Provide Quick Ratio
for Recordati Industria Chimica e Farmaceutica SpA.
Provide Current Ratio
for Recordati Industria Chimica e Farmaceutica SpA.
Provide Cash Ratio
for Recordati Industria Chimica e Farmaceutica SpA.
What is the historical Revenue growth
over the last 5 years for Recordati Industria Chimica e Farmaceutica SpA?
What is the historical Net Income growth
over the last 5 years for Recordati Industria Chimica e Farmaceutica SpA?
What is the current Free Cash Flow
of Recordati Industria Chimica e Farmaceutica SpA?
Discuss the annual earnings per share (EPS)
trend over the past five years for Recordati Industria Chimica e Farmaceutica SpA.
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
IT |
![]() |
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
|
10.4B EUR | 18 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
699.5B USD | 42.5 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 17 702.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
368.8B USD | 16.1 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.9T DKK | 14.3 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
208.7B CHF | 12.1 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
167.6B GBP | 192.8 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
186.3B CHF | 14.1 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
206.3B USD | 9.7 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
162.4B USD | 650.8 |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
119.8B EUR | 13.3 |
|
EBIT Growth | EV/EBIT to Growth | |||||
---|---|---|---|---|---|---|
IT |
![]() |
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
|
Average EV/EBIT:
1 698.7
18
|
15%
|
1.2 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
42.5
|
33%
|
1.3 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
17 702.3
|
98%
|
180.6 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
16.1
|
12%
|
1.3 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
14.3
|
16%
|
0.9 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
12.1
|
9%
|
1.3 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
192.8
|
21%
|
9.2 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
14.1
|
8%
|
1.8 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
9.7
|
12%
|
0.8 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
650.8
|
N/A | N/A |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
13.3
|
14%
|
0.9 |
|
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.